Bristol Myers plans to double experimental treatments to expand research pipeline Ruchika Sharma17 Sept 2023 3:00 PM ISTNew York: Bristol Myers Squibb has said it plans to double the number of treatments it is testing in clinical trials, with a focus on cell therapies,...
Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sept 2023 11:31 AM ISTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Giovanni Caforio to retire as Bristol Myers Squibb CEO Ruchika Sharma30 April 2023 1:30 PM ISTNew York: Bristol Myers Squibb has announced that Giovanni Caforio, MD, Chairman of the Board and Chief Executive Officer, has decided to retire...
Pfizer, Bristol Myers, AbbVie drugs likely to face US price negotiation Ruchika Sharma14 March 2023 3:30 PM ISTNovo Nordisk's diabetes drug Ozempic, prostate cancer treatment Xtandi from Astellas Pharma and Pfizer, and J&J's blood thinner Xarelto are on three...
Bayer Thrombosis drug Asundexian shows positive study result Ruchika Sharma5 April 2022 10:00 AM ISTAsundexian is a so-called factor 11a inhibitor and was being compared to a drug sold under the brand name Eliquis by Pfizer and Bristol-Myers Squibb...
Indoco Remedies Blood-thinner Apixaban gets USFDA green flag Ruchika Sharma14 Sept 2020 3:02 PM ISTIt is used for patients with health problems caused by a blood clot.
Indoco Remedies Blood-thinner Apixaban gets USFDA green flag Ruchika Sharma14 Sept 2020 3:02 PM ISTIt is used for patients with health problems caused by a blood clot.
Bristol Myers anticipates recovery in sales of hospital-administered drugs, raises annual profit forecast Ruchika Sharma9 Aug 2020 9:15 AM ISTUS: Bristol Myers Squibb Co (BMY.N) on Thursday raised its annual profit forecast as it predicted a recovery in sales of its...
New blood thinner antidote to help doctors move past warfarin savita thakur thakur25 Dec 2015 11:26 PM ISTBy Bill BerkrotNew York: A new class of blood thinners that competes with widely used warfarin should get a boost next year when an "antidote" that...
